Skip to main content
All lobbying filings

EAST END GROUP, LLC

Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products

 Filing 3rd Quarter - Termination (No Activity)
3rd Quarter (July 1 - Sep 30) 2026 · New Jersey · $45,000.00 income · posted Jul 15, 2026

Official filing document

 Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem